The first B2B (Bench to Bedside) Prostate Cancer Meeting was held at Medipol Mega University Hospital in Istanbul. Besides of Prof. Dr. Jean de la Rosette who is the General Secretary of SIU, Prof. Dr. Sabahattin Aydin who is the Rector of Medipol University, Prof. Dr. Gurkan Ozturk who is the Director of Medipol University Regenerative and Restorative Research Center, Prof. Dr. Selami Albayrak who is theProvincial Health Director of Istanbul and Prof. Dr. Gazi Yigitbasi who is the Director Medical of Medipol Mega University’s Hospital and world’s leading academicians and researchers attended the meeting today as well. The topics of the B2B–Prostate Cancer meeting range from prostate cancer stem cells to molecular imaging, engineering and clinical reflection of rapid advancements in research.
The first of the B2B (Bench to Bedside) panel series, co-organised by International Society of Urology and Medipol University, focused on prostate cancer and took place in Medipol University Hospital. REMER researchers Asst. Prof. Mustafa Güzel, Asst. Prof. Esra Çağavi, Asst. Prof. Emre Karakoç and lecturer Yasemin Yozgat presented their talks; while, Prof.Dr. Ertuğrul Kılıç and Asst. Prof. Cüneyd Parlayan chaired the sessions.
- Efficacious Androgen Receptor Antagonists: Novel Drug Discovery / Mustafa Guzel
- Reprogramming mechanism in normal physiology and in cancer : Similarities, Opportunities and Challenges / Esra Cagavi
- Common cancers: lung, ovary, breast, colorectal cancer and prostate / Emre Karakoc
- Circulating Tumor Cells: individual level surrogates / Yasemin Yozgat